Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.661
-0.021 (-2.97%)
Oct 1, 2024, 10:16 AM EDT - Market open
Klotho Neurosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2011 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '11 Dec 31, 2011 |
| Net Income | -1.39 | -0.71 | -0.6 | -1.11 | -0.91 | -0.52 | |
| Stock-Based Compensation | 0.04 | - | 0 | 0.82 | 0.75 | - | |
| Other Operating Activities | 0.29 | - | - | - | - | 0.25 | |
| Change in Accounts Payable | -0.18 | 0.1 | 0 | -0.01 | - | - | |
| Change in Other Net Operating Assets | 0.11 | 0.13 | -0.01 | 0.02 | - | - | |
| Operating Cash Flow | -1.13 | -0.47 | -0.6 | -0.28 | -0.17 | -0.27 | |
| Sale (Purchase) of Intangibles | -0.08 | 0.02 | -0.13 | - | - | - | |
| Investing Cash Flow | -0.08 | 0.02 | -0.13 | - | - | - | |
| Long-Term Debt Issued | - | 0.02 | - | - | - | - | |
| Net Debt Issued (Repaid) | 0.97 | 0.02 | - | - | - | - | |
| Issuance of Common Stock | 0.28 | 0.1 | 0.75 | 0.25 | 0.5 | 0.56 | |
| Other Financing Activities | 0.77 | 0.25 | -0.25 | - | - | -0.29 | |
| Financing Cash Flow | 2.02 | 0.37 | 0.5 | 0.25 | 0.5 | 0.27 | |
| Net Cash Flow | 0.8 | -0.07 | -0.22 | -0.03 | 0.33 | 0 | |
| Free Cash Flow | -1.13 | -0.47 | -0.6 | -0.28 | -0.17 | -0.27 | |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | - | - | |
| Cash Interest Paid | 0.04 | 0.08 | 0.02 | - | - | - | |
| Levered Free Cash Flow | -0.17 | 0.11 | -0.75 | - | - | - | |
| Unlevered Free Cash Flow | -0.14 | 0.16 | -0.74 | - | - | - | |
| Change in Net Working Capital | -0.56 | -0.53 | 0.25 | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.